Anti-MOG antibody-positive meningoencephalitis without demyelinating lesions

Affiliations

¹ Department of Neurology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
² Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

Tetsuya Yamane et al. Pediatr Int. 2023 Jan-Dec.

. 2023 Jan-Dec;65(1):e15612.

doi: 10.1111/ped.15612.

¹ Department of Neurology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
² Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.

No abstract available

Keywords: autoimmune; infant; meningoencephalitis; myelin-oligodendrocyte glycoprotein; white matter.

References

1. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol. 2023;22:268-282.
1. Ogawa R, Nakashima I, Takahashi T, Kaneko K, Akaishi T, Takai Y, et al. MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm. 2017;4:e322.
1. Gombolay GY, Gadde JA. Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: a review. J Neuroimmunol. 2021;358:577653.
1. Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, et al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018;89:127-137.
1. Lin S, Long W, Wen J, Su Q, Liao J, Hu Z. Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: a novel phenotype. Mult Scler Relat Disord. 2022;68:104126.